5-aminolevulinic acid (5-ALA): Clinical Trials

3 trials of 5-aminolevulinic acid (5-ALA), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 31Completed 1

Follow 5-aminolevulinic acid (5-ALA): new trials by email Literature Review of 5-aminolevulinic acid (5-ALA) trials Research Report on 5-aminolevulinic acid (5-ALA)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients
5-aminolevulinic acid (5-ALA), Photodynamic therapy (PDT) - Amputation, Osseointegration
Not yet recruitingDartmouth-Hitchcock Medical Center102026-10-012026-07-29
Use Of The Dietary Supplement 5-ALA And Its Relationship With Sleep And Mood
5-Aminolevulinic Acid (5-ALA), Placebo - Insomnia, Nocturnal Awakening
Not applicableCompletedUniversity of Hawaii852012-01-012013-03-20
Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid
5-aminolevulinic acid (5-ALA) - Brain Cancer, Brain Tumors
Phase 3Completedmedac GmbH4151999-10-012012-04-26

Conditions studied

Brain Neoplasms (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Sponsors

Dartmouth-Hitchcock Medical Center (1)  ·  University of Hawaii (1)  ·  medac GmbH (1)

Countries

United States (2)

Top investigators

Beatriz L. Rodriguez, M.D. (1)  ·  Hans-Juergen Reulen, MD (1)  ·  Rosanne C. Harrigan, Ed.D. (1)  ·  Terry Shintani, M.D. (1)

Results publications

PMID 16648043